vimarsana.com
Home
Live Updates
Bitopertin Meets Primary Phase 2 Endpoint in Erythropoietic Protoporphyria : vimarsana.com
Bitopertin Meets Primary Phase 2 Endpoint in Erythropoietic Protoporphyria : vimarsana.com
Bitopertin Meets Primary Phase 2 Endpoint in Erythropoietic Protoporphyria
Topline results from AURORA indicate that while bitopertin significantly reduced PPIX levels, improvements in light tolerance were not statistically significant.
Related Keywords
Matt Brown Unsplash ,
John Quisel ,
Drug Administration ,
Disc Medicine Inc ,
Patient Global Impression ,
Disc Medicine ,